List of Excipients in API insulin lispro
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing insulin lispro
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| A-S Medication Solutions | HUMALOG | insulin lispro | 50090-4488 | GLYCERIN | |
| A-S Medication Solutions | HUMALOG | insulin lispro | 50090-4488 | HYDROCHLORIC ACID | |
| A-S Medication Solutions | HUMALOG | insulin lispro | 50090-4488 | METACRESOL | |
| A-S Medication Solutions | HUMALOG | insulin lispro | 50090-4488 | PHENOL | |
| A-S Medication Solutions | HUMALOG | insulin lispro | 50090-4488 | SODIUM HYDROXIDE | |
| A-S Medication Solutions | HUMALOG | insulin lispro | 50090-4488 | SODIUM PHOSPHATE, DIBASIC | |
| A-S Medication Solutions | HUMALOG | insulin lispro | 50090-4488 | WATER | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for insulin lispro
Excipient focus: GLYCERIN
insulin lispro drug variants containing GLYCERIN
insulin lispro drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
insulin lispro drug variants containing HYDROCHLORIC ACID
insulin lispro drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM CHLORIDE
insulin lispro drug variants containing MAGNESIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin lispro-aabc | 0002-7728 |
| >Company | >Ingredient | >NDC |
insulin lispro drug variants not containing MAGNESIUM CHLORIDE
Excipient focus: METACRESOL
insulin lispro drug variants containing METACRESOL
insulin lispro drug variants not containing METACRESOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PHENOL
insulin lispro drug variants containing PHENOL
insulin lispro drug variants not containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Sanofi-Aventis US LLC | insulin lispro | 0024-5924 |
| Eli Lilly and Company | insulin lispro-aabc | 0002-7728 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROTAMINE SULFATE
insulin lispro drug variants containing PROTAMINE SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin lispro | 0002-7511 |
| Eli Lilly and Company | insulin lispro | 0002-7512 |
| Eli Lilly and Company | insulin lispro | 0002-8233 |
| Physicians Total Care Inc | insulin lispro | 54868-4381 |
| >Company | >Ingredient | >NDC |
insulin lispro drug variants not containing PROTAMINE SULFATE
Excipient focus: SODIUM HYDROXIDE
insulin lispro drug variants containing SODIUM HYDROXIDE
insulin lispro drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
insulin lispro drug variants containing SODIUM PHOSPHATE, DIBASIC
insulin lispro drug variants not containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin lispro-aabc | 0002-7728 |
| >Company | >Ingredient | >NDC |
Excipient focus: TREPROSTINIL SODIUM
insulin lispro drug variants containing TREPROSTINIL SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin lispro-aabc | 0002-7728 |
| >Company | >Ingredient | >NDC |
insulin lispro drug variants not containing TREPROSTINIL SODIUM
Excipient focus: TRISODIUM CITRATE DIHYDRATE
insulin lispro drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin lispro-aabc | 0002-7728 |
| >Company | >Ingredient | >NDC |
insulin lispro drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
insulin lispro drug variants containing WATER
insulin lispro drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC
insulin lispro drug variants containing ZINC
insulin lispro drug variants not containing ZINC
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin lispro | 0002-7511 |
| Eli Lilly and Company | insulin lispro | 0002-7512 |
| Eli Lilly and Company | insulin lispro | 0002-8233 |
| Sanofi-Aventis US LLC | insulin lispro | 0024-5924 |
| Eli Lilly and Company | insulin lispro-aabc | 0002-7728 |
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC OXIDE
insulin lispro drug variants containing ZINC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | insulin lispro | 0002-7511 |
| Eli Lilly and Company | insulin lispro | 0002-7512 |
| Eli Lilly and Company | insulin lispro-aabc | 0002-7728 |
| Eli Lilly and Company | insulin lispro | 0002-8233 |
| Sanofi-Aventis US LLC | insulin lispro | 0024-5924 |
| >Company | >Ingredient | >NDC |
insulin lispro drug variants not containing ZINC OXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
